PRICE T ROWE ASSOCIATES INC /MD/ - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 246 filers reported holding EDITAS MEDICINE INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$342
+16.3%
43,792
+22.7%
0.00%
Q2 2023$294
+15.3%
35,693
+1.7%
0.00%
Q1 2023$255
-4.9%
35,107
+16.1%
0.00%
Q4 2022$268
-99.9%
30,227
-12.7%
0.00%
Q3 2022$424,000
+16.5%
34,608
+12.5%
0.00%
Q2 2022$364,000
-23.5%
30,760
+23.0%
0.00%
Q1 2022$476,000
-24.0%
25,002
+6.1%
0.00%
Q4 2021$626,000
-64.5%
23,573
-45.1%
0.00%
Q3 2021$1,765,000
-19.4%
42,968
+11.2%
0.00%
Q2 2021$2,189,000
+63.1%
38,644
+20.9%
0.00%
Q1 2021$1,342,000
-29.0%
31,961
+18.6%
0.00%
Q4 2020$1,889,000
+355.2%
26,938
+82.3%
0.00%
Q3 2020$415,000
-94.1%
14,773
-94.9%
0.00%
-100.0%
Q1 2019$7,037,000
-41.1%
287,826
-45.2%
0.00%
-50.0%
Q4 2018$11,941,000
-51.4%
524,889
-32.1%
0.00%
-50.0%
Q3 2018$24,588,000
-12.5%
772,708
-1.4%
0.00%0.0%
Q2 2018$28,087,000
-5.1%
783,905
-12.2%
0.00%
-20.0%
Q1 2018$29,582,000
+7.2%
892,359
-0.6%
0.01%
+25.0%
Q4 2017$27,585,000
-7.0%
897,671
-27.3%
0.00%
-20.0%
Q3 2017$29,661,000
+21.0%
1,235,341
-15.4%
0.01%
+25.0%
Q2 2017$24,511,000
-21.7%
1,460,730
+4.2%
0.00%
-33.3%
Q1 2017$31,286,000
+18.1%
1,401,696
-14.1%
0.01%
+20.0%
Q4 2016$26,480,000
+4.8%
1,631,534
-13.0%
0.01%0.0%
Q3 2016$25,267,000
-24.5%
1,874,396
+32.5%
0.01%
-28.6%
Q2 2016$33,462,000
-29.1%
1,414,116
+0.3%
0.01%
-30.0%
Q1 2016$47,222,0001,409,8960.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders